AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 10.8 |
Market Cap | 1.02B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0.04 |
PE Ratio (ttm) | 270.5 |
Forward PE | n/a |
Analyst | Sell |
Ask | 17.29 |
Volume | 2,426,513 |
Avg. Volume (20D) | 546,957 |
Open | 10.81 |
Previous Close | 10.81 |
Day's Range | 10.75 - 10.91 |
52-Week Range | 7.52 - 11.38 |
Beta | undefined |
About ENFN
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and e...
Analyst Forecast
According to 6 analyst ratings, the average rating for ENFN stock is "Sell." The 12-month stock price forecast is $9, which is a decrease of -16.82% from the latest price.
Next Earnings Release
Analysts project revenue of $54.39M, reflecting a 17.00% YoY growth and earnings per share of 0.06, making a 50.00% increase YoY.
1 day ago · https://thefly.com
Clearwater-Enfusion merger makes sense strategically, says OppenheimerClearwater Analytics + Enfusion +0.76 (+7.61%)